# Marc Subirats

> Marc Subirats is a seed investor at Nina Capital (Barcelona) backing Health Care and Apps. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Nina Capital](https://shizune.co/investors/profile/nina-capital)
- Location: Barcelona, Spain
- Total investments: 7
- Last investment: Oct 2025
- Lead investor: 86%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/marc-subirats-38882a7/

Marc Subirats is a seed investor at Nina Capital in Barcelona focused on Health Care and Apps. Marc Subirats is the Partner at Nina Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Apps | 1 | 14% |
| Medical | 1 | 14% |
| Software | 1 | 14% |
| Life Science | 1 | 14% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 57% |
| Pre-Seed | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 1 | 14% |
| Bulgaria | 1 | 14% |
| United States | 1 | 14% |
| United Kingdom | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| io Health | Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare. | $2M | Seed | Oct 07, 2025 |  |
| Lillian Care | Lillian is building a nationwide network of health facilities in Germany. | $1.6M | Seed | Jun 18, 2024 |  |
| Zetta Genomics | Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England. | $2.3M | Seed | Feb 08, 2024 |  |
| Lillian Care | Lillian is building a nationwide network of health facilities in Germany. | $2.6M | Pre-Seed | Aug 01, 2023 |  |
| Zetta Genomics | Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England. | $2.4M | Seed | Apr 17, 2023 |  |
| Healee | Healee is a telehealth platform which benefits doctors and patients through convenient and accessible virtual contact. | $2M | Seed | Aug 30, 2022 |  |
| Zetta Genomics | Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England. | $3.4M | Seed | Feb 01, 2022 |  |

7 of 7 investments shown.

## Co-investors
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-12df) — VC Fund, 3 deals together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-2) — VC Fund, 3 deals together
- [Calm/Storm VC](https://shizune.co/investors/profile/calm-storm-ventures) — VC Fund, 3 deals together
- [University of Cambridge Enterprise](https://shizune.co/investors/profile/university-of-cambridge-enterprise) — VC Fund, 3 deals together
- [Aescuvest](https://shizune.co/investors/profile/aescuvest) — VC Fund, 1 deal together
- [Atlantis Ventures](https://shizune.co/investors/profile/atlantis-ventures) — VC Fund, 1 deal together

## About Nina Capital

VC Fund · Barcelona, Spain

Investing in healthcare transformation powered by information technology led by need-driven founders.

5 contacts available at Nina Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Giangiacomo Rocco | Venture Partner | https://shizune.co/investors/profile/giangiacomo-rocco |
| Jordi Pedrol | Head of Finance | https://shizune.co/investors/profile/jordi-pedrol |
| Marc Subirats | General Partner | https://shizune.co/investors/profile/marc-subirats |
| Marta G. Zanchi | Founder & Managing Partner | https://shizune.co/investors/profile/marta-gaia-zanchi |
| Matthew Holt | Venture Partner | https://shizune.co/investors/profile/matthew-holt |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Marc Subirats invest in?

Marc Subirats invests primarily in Health Care, Apps and Medical startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Marc Subirats last invest?

The most recent investment recorded for Marc Subirats closed in Oct 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co